Record Display for the EPA National Library CatalogRECORD NUMBER: 1 OF 3
|EPA's Endocrine Disruptor Screening Program Should Establish Management Controls to Ensure More Timely Results. Evaluation Report.
|R. Beusse ; H. C. Garduno ; K. Good ; R. McGhee-Lenart ; J. Narimatsu
|Environmental Protection Agency, Washington, DC. Office of the Inspector General.
|Toxic substances ; Endocrine effects ; Management controls ; Testing ; Screening ; Androgenic effects ; Thyroid effects ; Recommendations ; Human health ; Environmental effects ; Endocrine diseases ; Achievements ; Monetary benefits ; Endocrine-disrupting chemicals ; Environmental Protection Agency (EPA) ; Endocrine Disruptor Screening Program (EDSP)
We sought to determine whether the U.S. Environmental Protection Agency (EPA) has planned and conducted the requisite research and testing to evaluate and regulate endocrine-disrupting chemicals. We focused on EPA's Endocrine Disruptor Screening Program (EDSP) because it is the program that focuses on screening and testing chemicals with endocrine-disrupting effects. In 1996, Congress passed the Food Quality Protection Act (FQPA), which gave EPA the authority to screen and test substances that may have an effect in humans that is similar to that of a naturally occurring estrogen, or such other endocrine effects as the EPA Administrator may designate. In 1998, EPA established the EDSP, which uses a two-tiered screening and testing approach to assess endocrine effects. EDSP was expanded to include androgenic and thyroid effects.